4//SEC Filing
Madison Greg 4
Accession 0001114220-18-000016
CIK 0001114220other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:19 PM ET
Size
8.4 KB
Accession
0001114220-18-000016
Insider Transaction Report
Form 4
Madison Greg
See Remarks
Transactions
- Award
Common Stock
2017-11-07+125,000→ 492,620 total - Award
Common Stock
2018-01-29$4.81/sh−4,403$21,178→ 429,404 total - Tax Payment
Common Stock
2017-11-07$5.15/sh−58,813$302,887→ 433,807 total
Footnotes (4)
- [F1]The 125,000 shares are shares of common stock that were delivered to the reporting person upon the achievement of a performance condition associated with a portion of a restricted stock award that was granted on April 30, 2015.
- [F2]A total of 58,813 shares of common stock were surrendered by Mr. Madison and returned to the company in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of the 125,000 shares of restricted stock on November 6, 2017.
- [F3]Sale of a total of 4,403 shares of common stock was made in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of 12,812 shares of restricted stock on January 26, 2018. Mr. Madison had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F4]Includes 201,248 shares of restricted stock.
Documents
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeother
Related Parties
1- filerCIK 0001564955
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 5:19 PM ET
- Size
- 8.4 KB